CA2531329A1 - Family of 28 kda babesia proteins as vaccines - Google Patents

Family of 28 kda babesia proteins as vaccines Download PDF

Info

Publication number
CA2531329A1
CA2531329A1 CA002531329A CA2531329A CA2531329A1 CA 2531329 A1 CA2531329 A1 CA 2531329A1 CA 002531329 A CA002531329 A CA 002531329A CA 2531329 A CA2531329 A CA 2531329A CA 2531329 A1 CA2531329 A1 CA 2531329A1
Authority
CA
Canada
Prior art keywords
protein
nucleic acid
proteins
vaccine
canis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002531329A
Other languages
English (en)
French (fr)
Inventor
Bernard Piere Dominique Carcy
Andre Francois Gorenflot
Theodorus Petrus Maria Schetters
Prisca Laetitia Cibrelus
Karina Moubri
Delphine Depoix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2531329A1 publication Critical patent/CA2531329A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA002531329A 2003-07-10 2004-07-12 Family of 28 kda babesia proteins as vaccines Abandoned CA2531329A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03077178.6 2003-07-10
EP03077178 2003-07-10
PCT/EP2004/051454 WO2005012343A1 (en) 2003-07-10 2004-07-12 Babesia vaccines

Publications (1)

Publication Number Publication Date
CA2531329A1 true CA2531329A1 (en) 2005-02-10

Family

ID=34112460

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002531329A Abandoned CA2531329A1 (en) 2003-07-10 2004-07-12 Family of 28 kda babesia proteins as vaccines

Country Status (8)

Country Link
US (1) US7722879B2 (enExample)
EP (1) EP1646647A1 (enExample)
JP (1) JP4887144B2 (enExample)
AU (1) AU2004260737B2 (enExample)
BR (1) BRPI0412419A (enExample)
CA (1) CA2531329A1 (enExample)
WO (1) WO2005012343A1 (enExample)
ZA (1) ZA200600180B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583139C1 (ru) * 2014-11-13 2016-05-10 Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" Способ пролонгированной химиопрофилактики пироплазмидозов крупного рогатого скота

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2658568A1 (en) * 2010-12-29 2013-11-06 Intervet International B.V. Canine babesiosis vaccine antigen
EP2626365A1 (en) * 2012-02-10 2013-08-14 MegaCor Diagnostik GmbH Compounds and methods for the diagnosis of babesia canis canis infection
DK201970598A1 (en) 2019-09-09 2021-05-17 Apple Inc Techniques for managing display usage
US20230190905A1 (en) * 2021-09-28 2023-06-22 The United States Of America, As Represented By The Secretary Of Agriculture Transmission-blocking vaccine against babesia
WO2025118050A1 (pt) * 2023-12-04 2025-06-12 Laboratório Bio-Vet Ltda Antígeno vacinal quimérico com ação tríplice contra erliquiose, anaplasmose e babesiose canina, vetor de expressão, célula recombinante, composição vacinal, kit de diagnóstico, método de tratamento e uso de proteína quimérica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903038A1 (en) 1989-08-23 1991-02-27 Commw Scient Ind Res Org Antigens and polypeptides derived from babesia (12d3¹antigen)
EP1050541A1 (en) 1999-04-29 2000-11-08 Akzo Nobel N.V. Babesia vaccine
EP1268856A2 (de) * 2000-04-07 2003-01-02 Epigenomics AG Detektion von snp's und cytosin-methylierungen
EP1238983A1 (en) 2001-03-06 2002-09-11 Akzo Nobel N.V. "Babesia canis vaccine"

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2583139C1 (ru) * 2014-11-13 2016-05-10 Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" Способ пролонгированной химиопрофилактики пироплазмидозов крупного рогатого скота

Also Published As

Publication number Publication date
AU2004260737A1 (en) 2005-02-10
BRPI0412419A (pt) 2006-08-22
US20070041991A1 (en) 2007-02-22
EP1646647A1 (en) 2006-04-19
JP2008500802A (ja) 2008-01-17
WO2005012343A1 (en) 2005-02-10
US7722879B2 (en) 2010-05-25
ZA200600180B (en) 2007-02-28
JP4887144B2 (ja) 2012-02-29
AU2004260737B2 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
US7722879B2 (en) Babesia vaccines
US9346862B2 (en) Canine babesiosis vaccine antigen
US7799330B2 (en) Piroplasmid vaccine
US6203801B1 (en) Coccidiosis polypeptide and vaccines
EP1238983A1 (en) "Babesia canis vaccine"
US7090849B2 (en) Babesia canis vaccine
US20110053148A1 (en) Coccidiosis vaccines
EP1539820A2 (en) Ostertagia vaccine
MXPA06002871A (en) Piroplasmid vaccine
IL147888A (en) Vaccine for rabies in animals from the canine family and methods for its preparation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130416